WebCastle Biosciences (CSTL) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... ETF News Global Markets News Expert Spotlight TipRanks Labs Earnings Reports Insights Market Breakdowns Dividend Stock News Crypto News. WebApr 12, 2024 · Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, …
Castle Biosciences (CSTL) Price To Cash Flow - Zacks.com
WebThe Committee on Science, Technology, and Law (CSTL) brings experts in science, engineering, and medicine together with members of the legal and policy communities … WebCSTL NEWS. CSTL NEWS FROM IBD; CSTL NEWS - IBD PARTNERS; IBD. Stocks With Rising Relative Strength: Castle Biosciences. Investor's Business Daily 09/23/2024 03:00 AM ET. Stocks To Watch: Castle Biosciences Sees RS Rating Jump To 84. Investor's Business Daily 08/24/2024 03:00 AM ET. Castle Biosciences Getting Closer To Key … philipp knauber contwig
Center for Cytokine Storm Treatment & Laboratory CSTL
WebView the latest Castle Biosciences Inc. (CSTL) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebCSTL Stock 12 Months Forecast. $42.60. (91.37% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Castle Biosciences in the last 3 months. The average price target is $42.60 with a high forecast of $50.00 and a low forecast of $38.00. The average price target represents a 91.37% change from the last price of $22.26. WebRead St. Louis, MO and Missouri latest headlines. Get the latest on weather, sports, entertainment, lifestyles, and more. philipp knobelspies